Last update 23 Jan 2025
Meryx, Inc.

Meryx, Inc.

Holding Company|
2013|
North Carolina, United States
|
< 10
|
www.meryxpharma.com

Overview

Tags

Immune System Diseases
Hemic and Lymphatic Diseases
Neoplasms
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Immune System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
FLT3 x MerTK1

Related

2
Drugs associated with Meryx, Inc.
MRX-2843
Target
FLT3 x MerTK
Mechanism
FLT3 inhibitors [+1]
Active Org.
Meryx, Inc.Meryx, Inc. [+1]
Originator Org.
Meryx, Inc.Meryx, Inc.
Active Indication
Refractory acute myeloid leukemia [+6]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
MRX-6313
Target
FLT3 x RTK
Mechanism
FLT3 inhibitors [+1]
Active Org.-
Originator Org.
The University of North Carolina at Chapel HillThe University of North Carolina at Chapel Hill
Active Indication-
Inactive Indication
Hematologic Neoplasms [+1]
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
2
Clinical Trials associated with Meryx, Inc.
NCT04872478
/ RecruitingPhase 1
An Open Label Evaluation Phase 1 Trial of the Safety and Pharmacokinetics of MRX-2843 in Adolescents and Adults with Relapsed/Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Mixed Phenotype Acute Leukemia
NCT03510104
/ Active, not recruitingPhase 1
A Phase I Dose Escalation Study of the Safety, Pharmacokinetics and Pharmacodynamics of MRX-2843 in Adult Subjects with Relapsed/Refractory Advanced And/or Metastatic Solid Tumors
100 Clinical Results associated with Meryx, Inc.
Login to view more data
0 Patents (Medical) associated with Meryx, Inc.
Login to view more data
100 Deals associated with Meryx, Inc.
Login to view more data
100 Translational Medicine associated with Meryx, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 24 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
MRX-2843
 ( FLT3 x MerTK )		Mixed phenotype acute leukemia
More
Phase 1
MRX-6313
 ( FLT3 x RTK )		Solid tumor
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free